CHRISTUS Health Selects Five Elsevier Clinical Decision Support Solutions To Transform Care Delivery For Patients, Physicians, Nurses And Pharmacists

Partnership with Elsevier Facilitates Continuation of System’s Nine-Year “Journey to Excellence”; Elsevier becomes primary information source for clinicians

Philadelphia, PA, 10 August 2009 – Elsevier, a world leader in healthcare and medical publishing and online solutions, today announced that Dallas-based CHRISTUS Health, one of the top 10 Catholic health systems in the U.S., will install five of Elsevier’s online clinical decision support (CDS) solutions to meet the diverse and evolving clinical decision support needs of its physicians, nurses and pharmacists.

CHRISTUS opted for Elsevier’s comprehensive, interdisciplinary and integrated suite of CDS solutions for pharmacy, medicine and nursing. Among the selected solutions are Clinical Pharmacology, which delivers expert drug information; ToxED 2.0, which facilitates treatment of drug overdose emergencies; First Consult, which provides evidence-based answers for the point of care; MD Consult, which brings leading medical resources together in a single online service; and Mosby’s Nursing Consult, which helps nurses find answers to pressing clinical questions.

“Elsevier looks forward to providing CHRISTUS Health clinicians with CDS solutions that deliver timely, consistent, accurate information for enhanced diagnostic and treatment decision making,” said Scott Wilson, Vice President, Clinical Decision Support Sales. “When physicians, nurses and pharmacists access the same high-level evidence-based content, they are better positioned to coordinate care, engage patients and families and improve quality, safety and efficiency.”

Elsevier CDS solutions will be installed in 25 Texas hospitals within CHRISTUS Health, which is composed of more than 40 hospitals, inpatient and long-term care facilities, as well as multiple clinics, physician offices and healthcare services.

“CHRISTUS Health has been on its Journey to Excellence since 2000, and adoption of multiple Elsevier CDS solutions will enable progress in each of our directions of excellence: clinical quality, service delivery, business literacy and community value,” said Thomas Royer, M.D., President and CEO of CHRISTUS Health. “CHRISTUS Health’s ability to continue our Journey means providing our physicians, nurses, pharmacists and associates with advanced clinical decision support tools to deliver absolute excellence.”

Other factors influencing CHRISTUS’ decision to adopt multiple Elsevier solutions included its need to consolidate resources, save on costs, integrate solutions and allow physicians, nurses and pharmacists to navigate effortlessly between CDS products. For example, a clinician can move seamlessly from MD Consult to Clinical Pharmacology, without logging in and out of multiple programs, saving time and effort.

“CHRISTUS is convinced that online decision support solutions play a vital role in fulfilling the system’s mission,” Royer said. “The implementation and use of Elsevier’s multiple solutions will help us to create services, process and structures that improve the health of individuals and local and global communities.”

About CHRISTUS HealthHeadquartered in Dallas, CHRISTUS Health is a faith-based, not-for-profit health system comprised of more than 40 hospitals, inpatient and long-term care facilities as well as dozens of clinics, physician offices and health care services in more than 70 cities in Texas, Arkansas, Louisiana, Oklahoma, Utah and Mexico. To provide care and support for patients, the system employs 30,000 Associates, with 9,000 physicians on facility medical staffs. CHRISTUS Health is listed among the top ten Catholic health systems in the U.S.

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries.

Media Contact:
Tom Reller
+1 215 239 3508